Elma Research International

The latest episode of the Bridging the Gap podcast is now available, featuring Georgia Sturt from Bowel Research UK. This episode looks at the crucial role clinician-led studies play in improving patient outcomes, especially for those facing conditions that aren't often prioritized by commercial research. We also explore the challenges of early diagnosis and the vital need for innovation in screening methods.   🎧 Listen to the latest episode here: Apple: https://lnkd.in/ebrUNn3g Spotify: https://lnkd.in/eDN8h3G2 Podbean: https://lnkd.in/eWJdqGcW #BowelresearchUK #elmaresearch #bridgingthegap #podcast #leadingwithideas

PeriScope is the Elma Research International syndicated competitive messaging intelligence monitor. The service explores conversations, uncovers nuanced sentiments and reveals emerging themes; painting a comprehensive picture of messaging performance versus your competition. Today, the service is active across CLL, UC/CD, RCC, NSCLC, MM and more… Contact us if you are interested in the results of Q4 2024 or are looking to sign-up for our 2025 reports!

This week we’ve launched the Bridging the Gap podcast, which shares conversations with organisations representing patient needs and leading research into a wide range of diseases affecting people across the world. The aim of this podcast is to highlight some of the key challenges associated with living with various conditions and to explore opportunities to bridge the gap between today’s healthcare provision and the needs of different patient communities.   Our first episode features Nick Palmer from Kidney Care UK where we explore the critical topic of chronic kidney disease.   🎧 Listen to Episode 1 Now: Apple: https://lnkd.in/ebrUNn3g Spotify: https://lnkd.in/eDN8h3G2 Podbean: https://lnkd.in/eWJdqGcW   Watch this space for further conversations in the coming weeks on a wider range of disease areas. Subscribe today and join us in our mission to bridge the gap between healthcare systems and patient communities across the world. #kidneycareuk #elmaresearch #bridgingthegap #podcast #leadingwithideas

Join us in raising awareness with Kidney Care UK for our unsung heroes - our kidneys! They are #BloodyAmazing but can silently lose function. Check your CKD risk by visiting https://lnkd.in/dVgnEDFf Watch this space for our new podcast series launching later this month, where in one of our newest episodes we discuss the challenges of living with CKD with Kidney Care UK. #BloodyAmazingKidneys

Today marks World Mental Health Day. We know from extensive patient research that the physical burden of living with diseases is only one side of the equation. Our work through the Hero’s Journey shows that patients across therapy areas face significant challenges to mental wellbeing as they come to terms with diagnosis, accept the realities of living with a condition and look to move forward in their ‘new normal’. This is why Elma Research International are advocates for mental health support in conjunction with pharmaceutical treatment, through improved education and support groups.   #WorldMentalHealthDay #elmaresearch #leadingwithideas #marketresearch #insight 

Weight-loss drugs are likely to supercharge a rush towards strength training equipment with the impact on gyms being huge. GLP-1’s represent a profound opportunity for the fitness and wellness industry offering a new pathway to successful weight loss & weight maintenance. Elma’s extensive research into obesity has consistently shown that GLP-1s should be integrated into a holistic wellness programme of interventions and never replace exercise and healthy eating. It’s exciting to see that pharmacological intervention can and will lead to healthier life choices. #obesity #glp-1 #lilly #novonordisk   https://lnkd.in/eQQgU_5G

Weight-loss drugs are likely to supercharge a rush towards strength training equipment with the impact on gyms being huge. GLP-1’s represent a profound opportunity for the fitness and wellness industry offering a new pathway to successful weight loss & weight maintenance. Elma’s extensive research into obesity has consistently shown that GLP-1s should be integrated into a holistic wellness programme of interventions and never replace exercise and healthy eating. It’s exciting to see that pharmacological intervention can and will lead to healthier life choices. #obesity #glp-1 #lilly #novonordisk   https://lnkd.in/eQQgU_5G

Exciting developments in the Lupus Landscape – fantastic to see so much investment in treating Lupus #lupus #differentiationdiscovery https://lnkd.in/dbs9_sds

We’ve seen fantastic engagement through our most recent round of Elma Educates sessions with insight teams at pharma companies. Recent sessions have focused on how to turn business needs into research objectives and how to sell the value of research to key stakeholders in the business. We’re always keen to learn more about other topics that could be relevant to insight teams. Comment below with what topics or sessions you would like us to run. #elmaresearch #leadingwithideas #marketresearch #insight #training

PeriScope is the Elma Research International competitive messaging intelligence monitor. The service explores conversations, uncovers nuanced sentiments and reveals emerging themes; painting a comprehensive picture of messaging performance versus your competition.   Today, the service is active in more than 25 therapeutic areas. Contact us if you are interested in the results of Q3 2024 and if you want to activate your PeriScope for Q4 2024!   Are we missing any therapeutic areas of interest? Comment below!   #elmaresearch #leadingwithideas #marketresearch #insight #periscope